Neonatal bacterial sepsis
Canberra Hospital and Health ServicesClinical GuidelineNeonatal bacterial sepsisContents TOC \h \z \t "Heading 1,1,Heading 2,2" Contents PAGEREF _Toc527461169 \h 1Guideline Statement PAGEREF _Toc527461170 \h 2Scope PAGEREF _Toc527461171 \h 2Section 1 – Introduction PAGEREF _Toc527461172 \h 2Blood investigations for sepsis: PAGEREF _Toc527461173 \h 3Section 2 – Early Onset Sepsis (EOS) PAGEREF _Toc527461174 \h 4Possible Causative Organisms (EOS): PAGEREF _Toc527461175 \h 4Risk Factors: PAGEREF _Toc527461176 \h 4Empiric Antibiotic Choice (Early onset sepsis): PAGEREF _Toc527461177 \h 5Section 3 – Late Onset Sepsis (LOS) in the NICU PAGEREF _Toc527461178 \h 5Causative Organisms PAGEREF _Toc527461179 \h 6Risk factors: PAGEREF _Toc527461180 \h 6Signs and symptoms: PAGEREF _Toc527461181 \h 6Investigations: PAGEREF _Toc527461182 \h 6Antibiotics in LOS in the NICU (source unknown): PAGEREF _Toc527461183 \h 7Implementation PAGEREF _Toc527461184 \h 8Related Policies, Procedures, Guidelines and Legislation PAGEREF _Toc527461185 \h 8References PAGEREF _Toc527461186 \h 8Definition of Terms PAGEREF _Toc527461187 \h 9Search Terms PAGEREF _Toc527461188 \h 10Attachments PAGEREF _Toc527461189 \h 10Attachment 1: Algorithm 1: Flow chart for management of suspected early onset sepsis in term and late preterm (from 34 weeks gestation) newborns on PNW/in NICU/SCN PAGEREF _Toc527461190 \h 11Attachment 2: Algorithm 2: Flow chart for newborns at risk of early onset sepsis <34 weeks in the NICU PAGEREF _Toc527461191 \h 12Attachment 3: Algorithm 3: Newborns attending ED or via the community midwives with suspected late onset sepsis PAGEREF _Toc527461192 \h 13Guideline StatementBackgroundNeonates and young infants are at high risk of severe bacterial infections with significant associated morbidity and mortality. Symptoms of early onset bacterial sepsis are often non-specific therefore a high index of suspicion is warranted. ?Due to the non-specific presentation of severe bacterial infection in this patient group, initial treatment is empiric (i.e. covering a range of likely bacteria). ?There is a lower threshold for intervention in preterm neonates than in term infants (see treatment algorithms).Key ObjectiveThis document provides algorithms to support the timely diagnosis and treatment of sepsis in newborn patients. Other objectives are to rationalise the use of antibiotics in suspected early onset sepsis and encourage the cessation of antibiotics in well infants at 36 hours post blood culture when there is a low clinical suspicion of infection.Alerts Antibiotics should be given within an hour of birth or diagnosis of suspected sepsis.Ensure when prescribing antimicrobials that the Antimicrobial Stewardship Procedure is considered and where applicable followed.Back to Table of ContentsScopeThis clinical guideline applies to newborns (<28 days or <28 days corrected gestational age if preterm) at risk of sepsis or presenting with suspected sepsis in:Neonatal Intensive Care (NICU) or Special Care Nursery (SCN)Postnatal wardsVia the emergency department/community midwives.Back to Table of ContentsSection 1 – IntroductionNeonatal sepsis is classified according to the infant's age at the onset of symptoms. For the purposes of this guideline early and late onset sepsis are defined as:Early-onset sepsis?is defined as the onset of symptoms occurring within the first 72 hours of life.Late-onset sepsis?is defined as the onset of symptoms at ≥72 hours of life. At the Canberra Hospital and Health Services (CHHS) there are four clinical scenarios for suspected sepsis that present in the newborn period each requiring a slightly different approach (See algorithms 1-3):Newborns >/=34 weeks gestation with suspected early onset sepsis (Algorithm 1)Newborns <34 weeks gestation with suspected early onset sepsis (Algorithm 2)Preterm newborns with suspected late onset sepsis in NICU/SCN Term or ex-preterm newborns with suspected late onset sepsis presenting via the emergency department or via the community midwives (Algorithm 3)Blood investigations for sepsis:Blood cultures: The majority of the time, blood cultures should be taken prior to starting antibiotics. If IV access is difficult in the setting of septic shock antibiotics should not be delayed to allow for a blood culture to be taken. At least 1 ml of blood should be taken (even for extremely low birth weight infants) as this improves the diagnostic yield of the test 2 fold ADDIN EN.CITE <EndNote><Cite><Author>Connell</Author><Year>2007</Year><RecNum>4</RecNum><DisplayText>(1)</DisplayText><record><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501551794">4</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Connell, T. G.</author><author>Rele, M.</author><author>Cowley, D.</author><author>Buttery, J. P.</author><author>Curtis, N.</author></authors></contributors><auth-address>Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Parkville, Australia.</auth-address><titles><title>How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>891-6</pages><volume>119</volume><number>5</number><keywords><keyword>Adolescent</keyword><keyword>Bacteremia/*blood/diagnosis</keyword><keyword>Bacteriological Techniques/methods/*standards</keyword><keyword>Child</keyword><keyword>Child, Preschool</keyword><keyword>False Negative Reactions</keyword><keyword>Hospitals/*standards</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Infant, Newborn</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>17473088</accession-num><urls><related-urls><url>;(1).Full Blood Count (FBC): Neutrophilia, neutropenia, thrombocytopenia and the immature/total neutrophil ratio (I/T ratio) are all associated with bacterial infection but are not individually sensitive or specific enough to rule out or rule in infection. The I/T ratio is a measure of the immature neutrophil count and is <0.22 in 96% of healthy preterm infants <32 weeks gestation ADDIN EN.CITE <EndNote><Cite><Author>Lloyd</Author><Year>1982</Year><RecNum>7</RecNum><DisplayText>(2)</DisplayText><record><rec-number>7</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501552168">7</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lloyd, B. W.</author><author>Oto, A.</author></authors></contributors><titles><title>Normal values for mature and immature neutrophils in very preterm babies</title><secondary-title>Arch Dis Child</secondary-title></titles><periodical><full-title>Arch Dis Child</full-title></periodical><pages>233-5</pages><volume>57</volume><number>3</number><keywords><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>*Infant, Premature</keyword><keyword>*Leukocyte Count</keyword><keyword>*Neutrophils</keyword><keyword>Reference Values</keyword></keywords><dates><year>1982</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1468-2044 (Electronic)
0003-9888 (Linking)</isbn><accession-num>7073305</accession-num><urls><related-urls><url>;(2). In healthy term infants the 90th percentile for IT ratio is 0.27 ADDIN EN.CITE <EndNote><Cite><Author>Schelonka</Author><Year>1994</Year><RecNum>9</RecNum><DisplayText>(3)</DisplayText><record><rec-number>9</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501553617">9</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schelonka, R. L.</author><author>Yoder, B. A.</author><author>desJardins, S. E.</author><author>Hall, R. B.</author><author>Butler, J.</author></authors></contributors><auth-address>Department of Pediatrics, Wilford Hall United States Air Force Medical Center, Lackland Air Force Base, Texas.</auth-address><titles><title>Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants</title><secondary-title>J Pediatr</secondary-title></titles><periodical><full-title>J Pediatr</full-title></periodical><pages>603-6</pages><volume>125</volume><number>4</number><keywords><keyword>Blood Cell Count</keyword><keyword>Gestational Age</keyword><keyword>Humans</keyword><keyword>Infant, Newborn/blood/*immunology</keyword><keyword>*Leukocyte Count</keyword><keyword>*Neutrophils</keyword><keyword>Reference Values</keyword></keywords><dates><year>1994</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0022-3476 (Print)
0022-3476 (Linking)</isbn><accession-num>7931882</accession-num><urls><related-urls><url>;(3). A negative IT ratio has a high negative predictive accuracy but a low positive predictive value. An IT ratio is the ratio of immature to mature neutrophils and is calculated as follows, immature neutrophils (promyelocytes + myelocytes+ metamyelocytes + bands)/total number of neutrophils (mature + immature)Acute phase reactants: There are a number of acute phase reactants that are being studied to assist in better diagnosing and monitoring neonatal sepsis. C-reactive protein (CRP) has been shown to have a low sensitivity early in the course of infection which improves 24-48 hours after the onset of symptoms ADDIN EN.CITE <EndNote><Cite><Author>Hofer</Author><Year>2012</Year><RecNum>8</RecNum><DisplayText>(4)</DisplayText><record><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501553254">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hofer, N.</author><author>Zacharias, E.</author><author>Muller, W.</author><author>Resch, B.</author></authors></contributors><auth-address>Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria. nora.hofer@medunigraz.at</auth-address><titles><title>An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks</title><secondary-title>Neonatology</secondary-title></titles><periodical><full-title>Neonatology</full-title></periodical><pages>25-36</pages><volume>102</volume><number>1</number><keywords><keyword>Biomarkers/blood</keyword><keyword>C-Reactive Protein/*analysis</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Sepsis/*blood/diagnosis</keyword></keywords><dates><year>2012</year></dates><isbn>1661-7819 (Electronic)
1661-7800 (Linking)</isbn><accession-num>22507868</accession-num><urls><related-urls><url>;(4). In the Department of Neonatology it is recommended to send a CRP at the onset of infective symptoms and a repeat CRP again 12 -24 hours later. Two normal CRP levels taken initially 8-24 hours after birth and again 24 hours later have a negative predictive value of 99.7% for culture proven sepsis ADDIN EN.CITE <EndNote><Cite><Author>Benitz</Author><Year>1998</Year><RecNum>10</RecNum><DisplayText>(5)</DisplayText><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501553805">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Benitz, W. E.</author><author>Han, M. Y.</author><author>Madan, A.</author><author>Ramachandra, P.</author></authors></contributors><auth-address>Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA 94304, USA.</auth-address><titles><title>Serial serum C-reactive protein levels in the diagnosis of neonatal infection</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>E41</pages><volume>102</volume><number>4</number><keywords><keyword>Bacteria/isolation & purification</keyword><keyword>Bacterial Infections/blood/*diagnosis/microbiology</keyword><keyword>Bayes Theorem</keyword><keyword>C-Reactive Protein/*analysis</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Infant, Newborn/blood</keyword><keyword>Male</keyword><keyword>Mycoses/blood/diagnosis</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prospective Studies</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Sepsis/blood/*diagnosis/microbiology</keyword></keywords><dates><year>1998</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>9755278</accession-num><urls><related-urls><url>;(5). There are reference ranges for a normal CRP in both term and preterm newborns that depend on age (6). In general a CRP of <10 mg/L is <95th percentile in a population of term and preterm infants (6).Administration of antibiotics:Antibiotics should be administered as soon as possible but definitely within 1 hour of birth/the decision to treat the newborn for suspected sepsis. The duration of treatment depends on the clinical picture and blood culture results and is at the discretion of the treating neonatologist. There is evidence to support that blood cultures positive for pathogens are positive by 36 hours (12). Whenever possible antibiotics should be ceased after 36 hours if blood cultures remain negative, the baby is well, the clinical suspicion of infection is low and inflammatory markers are reassuring(8). Back to Table of Contents Section 2 – Early Onset Sepsis (EOS)Early-onset infection is usually due to vertical transmission. Only around half of infants who develop EOS are symptomatic at birth PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LdXpuaWV3aWN6PC9BdXRob3I+PFllYXI+MjAxNzwvWWVh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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LdXpuaWV3aWN6PC9BdXRob3I+PFllYXI+MjAxNzwvWWVh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ADDIN EN.CITE.DATA (7). Well newborns >34 weeks gestation who have risk factors for sepsis require 4th hourly monitoring in the 12 hours following birth (see algorithm 1). Preterm newborns (<34 weeks) or clinically unwell newborns with suspected sepsis require pre-emptive treatment (see algorithm 2). The goal should be to start antibiotics within an hour of delivery or from when the decision to treat is made.Possible Causative Organisms (EOS):Group B streptococcus (Streptococcus agalactiae)E. coliHaemophilus influenzaeListeria monocytogenesOthers e.g. Staphylococcus aureus, Klebsiella sp, other enteric gram negative bacteriaRisk Factors: An infant is considered at risk for early onset neonatal sepsis if any of the following apply ADDIN EN.CITE <EndNote><Cite><Author>Excellence</Author><Year>2012</Year><RecNum>12</RecNum><DisplayText>(7)</DisplayText><record><rec-number>12</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501563062">12</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>National Institute for Healthcare Excellence</author></authors></contributors><titles><title>Neonatal infection (early onset): antibiotics for prevention and treatment</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(7)Evidence of clinical chorioamnionitis (deranged maternal observations: temperature > 38 0 C, HR > 100 / min, uterine tenderness, foul smelling vaginal discharge, rising CRP or white blood cell count and fetal heart rate > 160 bpm)Preterm labour at <37 weeks’ gestation ?Preterm prelabour rupture of membranes (PPROM) Prolonged rupture of membranes greater than 18 hours at term Group B Streptococcus (GBS) positive mother (GBS bacteriuria at any stage during pregnancy, previous GBS infected baby, known GBS carriage on antenatal swab who has not received adequate antibiotic cover in labour (defined as antibiotics given >4 hours prior to birth)?Evidence of infection in sibling in case of multiple pregnancyMaternal sepsis during labour or within 24 hours of delivery.Term and late preterm newborns at risk of early onset sepsis need close monitoring for the first 24-48 hours of life even if asymptomatic. Please refer to GBS guideline, Neonatal Early Warning Score (NEWS) charts and Prelabour Rupture of Membranes (PROM) guidelines for duration of in-patient observation). Sepsis Calculator ():A multivariate risk prediction tool has been developed that allows clinicians to estimate the risk of EOS taking clinical risk factors into account PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QdW9wb2xvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QdW9wb2xvPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48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ADDIN EN.CITE.DATA (9). This tool has been validated in clinical practice PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LdXpuaWV3aWN6PC9BdXRob3I+PFllYXI+MjAxNzwvWWVh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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LdXpuaWV3aWN6PC9BdXRob3I+PFllYXI+MjAxNzwvWWVh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ADDIN EN.CITE.DATA (7) and has been shown to reduce antibiotic use and blood tests in infants 35 weeks gestation and older without increasing morbidity or mortality. It can be used in newborns from 34 weeks gestation (see algorithm 1). Our local incidence of EOS for the purpose of calculator used is 0.7/1000 live births and should be set at 0.6/1000 live births when using the calculator. The criteria used for assessing clinical signs for the calculator are outlined below. Please refer to Attachment 1, algorithm 1.Well appearingNormal vital signs, well appearing newbornEquivocalPersistent (>4 hours) abnormal vital signs (HR>160, RR>60, temp instability, increased work of breathingORTwo or more abnormal vital signs >2 hoursClinical illnessPersistent need for NCPAP / HFNC / mechanical ventilation (outside of the delivery room)Hemodynamic instability requiring vasoactive drugsNeonatal encephalopathy /Perinatal depression (Seizures or Apgar <5 at 5 minutes)Need for supplemental O2 > 2 hours to maintain oxygen saturations > 90% (outside of the delivery roomEmpiric Antibiotic Choice (Early onset sepsis): Please note that if it is known that a mother is colonised with a pathogen empiric therapy for her newborn may need to be modified to cover for that organism in addition to usual pathogens. Please refer to algorithms 1 and 2 for suggested antibiotics.Back to Table of Contents Section 3 – Late Onset Sepsis (LOS) in the NICU Late onset sepsis occurs in 4.5% of newborns admitted to level III neonatal intensive care units in Australia and New Zealand ADDIN EN.CITE <EndNote><Cite><Author>report</Author><Year>2014</Year><RecNum>3</RecNum><DisplayText>(9)</DisplayText><record><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1500446197">3</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>ANZNN report</author></authors></contributors><titles></titles><dates><year>2014</year></dates><urls></urls></record></Cite></EndNote>(10) and is more common with decreasing gestational age. In the 2014 Australia and New Zealand Neonatal Network dataset, 33.9% of babies born <24 weeks, 30.7% of babies born at 24-25 weeks and 13% of babies born at 26-27 weeks develop late onset sepsis ADDIN EN.CITE <EndNote><Cite><Author>report</Author><Year>2014</Year><RecNum>3</RecNum><DisplayText>(9)</DisplayText><record><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1500446197">3</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>ANZNN report</author></authors></contributors><titles></titles><dates><year>2014</year></dates><urls></urls></record></Cite></EndNote>(10). By far the most common organism associated LOS in premature infants is Coagulase-Negative Staphylococci (CoNS).Causative OrganismsFig 1: Causative organisms for late onset sepsis at CHHS 2015-2017 (% of total positive cultures n=51)Risk factors:Prolonged hospitalisation due to any reason (e.g. prematurity, VLBW etc.)Delayed enteral feeding/prolonged central line usageMechanical ventilationPresence of foreign bodies (e.g. Intravenous catheter)Multiple invasive proceduresMalformations (e.g. Urinary tract anomalies)GBS positive mother in current pregnancy Signs and symptoms:The signs and symptoms of late onset sepsis are often very non-specific. It is important to consider sepsis whenever there is a change in the clinical status of a vulnerable newborn infant in the NICU.Investigations: Blood tests: FBC, CRP, blood gas, blood glucose, blood culture Also consider (if clinically indicated): Chest X-ray, Urine microscopy and cultureLumbar puncture: This should be performed at the discretion of the treating neonatologist ADDIN EN.CITE <EndNote><Cite><Author>Polin</Author><Year>2012</Year><RecNum>11</RecNum><DisplayText>(10)</DisplayText><record><rec-number>11</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501558498">11</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Polin, R. A.</author><author>Committee on, Fetus</author><author>Newborn,</author></authors></contributors><titles><title>Management of neonates with suspected or proven early-onset bacterial sepsis</title><secondary-title>Pediatrics</secondary-title></titles><periodical><full-title>Pediatrics</full-title></periodical><pages>1006-15</pages><volume>129</volume><number>5</number><keywords><keyword>Anti-Bacterial Agents/adverse effects/*therapeutic use</keyword><keyword>Bacteremia/diagnosis/*drug therapy/etiology</keyword><keyword>Bacteriological Techniques</keyword><keyword>Cooperative Behavior</keyword><keyword>Drug Administration Schedule</keyword><keyword>Evidence-Based Medicine</keyword><keyword>Female</keyword><keyword>Gestational Age</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>Infant, Premature, Diseases/*drug therapy</keyword><keyword>Interdisciplinary Communication</keyword><keyword>Microbial Sensitivity Tests</keyword><keyword>Pregnancy</keyword><keyword>Risk Factors</keyword><keyword>Sepsis/diagnosis/etiology/*therapy</keyword></keywords><dates><year>2012</year><pub-dates><date>May</date></pub-dates></dates><isbn>1098-4275 (Electronic)
0031-4005 (Linking)</isbn><accession-num>22547779</accession-num><urls><related-urls><url>;(11):When there is a pathogen isolated on blood culture (23% of bacteraemic newborns may have meningitis)When there are clinical signs or symptoms of meningitis (37% of newborns with meningitis have sterile blood cultures) When there is a strong clinical suspicion of sepsis with raised inflammatory markers despite a negative blood cultureWhen a patient is worsening despite antibiotic treatmentAntibiotics in LOS in the NICU (source unknown):This antibiotic recommendation is for empiric therapy when the source of the infection is unknown. If the source is known it may be appropriate to use a different antibiotic regimen (i.e. if treating pneumonia, meningitis, a Urinary Tract Infection (UTI) or suspected Necrotising enterocolitis (NEC). Consider what organisms the baby/mother are colonised with when making decisions about empiric therapy. This should be discussed with the treating neonatologist. The duration of treatment depends on the clinical picture and blood culture results and is at the discretion of the treating neonatologist. There is evidence to support that blood cultures positive for pathogens are positive by 36 hours ADDIN EN.CITE <EndNote><Cite><Author>Janjindamai</Author><Year>2006</Year><RecNum>13</RecNum><DisplayText>(11)</DisplayText><record><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1505185466">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Janjindamai, W.</author><author>Phetpisal, S.</author></authors></contributors><auth-address>Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand. jwaricha@medicine.psu.ac.th</auth-address><titles><title>Time to positivity of blood culture in newborn infants</title><secondary-title>Southeast Asian J Trop Med Public Health</secondary-title></titles><periodical><full-title>Southeast Asian J Trop Med Public Health</full-title></periodical><pages>171-6</pages><volume>37</volume><number>1</number><keywords><keyword>Algorithms</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>Intensive Care Units, Neonatal</keyword><keyword>Male</keyword><keyword>Microbiological Techniques</keyword><keyword>Predictive Value of Tests</keyword><keyword>Retrospective Studies</keyword><keyword>Sepsis/*diagnosis/drug therapy/microbiology</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0125-1562 (Print)
0125-1562 (Linking)</isbn><accession-num>16771231</accession-num><urls><related-urls><url>;(12). Whenever possible antibiotics should be ceased after 36 hours if blood cultures remain negative, the baby is well, the clinical suspicion of infection is low and inflammatory markers are reassuring ADDIN EN.CITE <EndNote><Cite><Author>Excellence</Author><Year>2012</Year><RecNum>12</RecNum><DisplayText>(7)</DisplayText><record><rec-number>12</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1501563062">12</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>National Institute for Healthcare Excellence</author></authors></contributors><titles><title>Neonatal infection (early onset): antibiotics for prevention and treatment</title></titles><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>(8). First lineIV Flucloxacillin and IV GentamicinConsider alternatives based on previous blood culture results or sensitivity patterns for the patient or motherFirst line IF risk factors AND high suspicion of infectionIV Flucloxacillin AND IV Amikacin Risk factors: Travel to a developing country/hospitalisation in a developing country in the past year. Known maternal colonisation with multi-resistant Gram negative organisms (if Amikacin sensitive)Severe sepsis/septic shockMeropenem and VancomycinBack to Table of ContentsSection 4 –Late onset sepsis in term newborns/term corrected newborns presenting via the Emergency Department (ED) or via the Midcall midwivesNewborns presenting from the community via the ED, the Midcall midwives or community nurses who are unwell with suspected sepsis should be readmitted to paediatrics or NICU depending on their age and on the severity of their symptoms. These babies should not routinely be readmitted to the postnatal ward (unless this has been discussed with the neonatologist on call) as the postnatal ward is not able to provide the necessary monitoring for a newborn with suspected sepsis. If a baby presents directly to the ward with suspected sepsis the neonatology registrar is responsible for making a timely assessment of their condition, discussing them with the neonatologist on call and referring them to paediatrics/NICU or ED depending on their clinical condition. Please refer to algorithm 3 for a suggested approach to assessment and management of this patient group.Back to Table of Contents Implementation This guideline will be available to all relevant staff on SharePoint. It will be incorporated into our orientation program. Stakeholders in the emergency department and paediatrics will educate their staff about the guideline.Back to Table of ContentsRelated Policies, Procedures, Guidelines and LegislationGuidelines Paediatrics - Acute Management of Fever Clinical Practice GuidelinePre-labour Rupture of Membranes (PROM) Management at TermEarly Onset Group B Streptococcus Disease (EOGBSD) (Maternity)Back to Table of ContentsReferences ADDIN EN.REFLIST 1.Connell TG, Rele M, Cowley D, Buttery JP, Curtis N. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics. 2007;119(5):891-6.2.Lloyd BW, Oto A. Normal values for mature and immature neutrophils in very preterm babies. Arch Dis Child. 1982;57(3):233-5.3.Schelonka RL, Yoder BA, desJardins SE, Hall RB, Butler J. Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr. 1994;125(4):603-6.4.Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102(1):25-36.5.Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102(4):E41.6. Chiesa C, Natale F, Pascone R et al, C-reactive protein and procalcitonin: Reference intervals for preterm and term newborns during the early neonatal period, Clinica Chimica Acta 412 (2011) 1053–1059 7.Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, et al. A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. JAMA Pediatr. 2017;171(4):365-71.8.National Institute of Clinical Excellence, Neonatal infection (early onset): antibiotics for prevention and treatment, August 2012 accessed on 01/08/2017..9.Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011;128(5):e1155-63.10.Chow S.S.W., Le Marseny R, Haslam R., Lui K, Report of the Australian and New Zealand Neonatal Network 2014, accessed from on the 01/08/2017.11.Polin RA, Committee on F, Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006-15.12.Janjindamai W, Phetpisal S. Time to positivity of blood culture in newborn infants. Southeast Asian J Trop Med Public Health. 2006;37(1):171-6.13.Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatrics. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8.14.NSW Clinical Excellence Commission, Sepsis kills Newborn Sepsis Pathway accessed from on the 06/09/2017.15.NSW health guideline: Maternity - Maternal Group B Streptococcus (GBS) and the Minimisation of Neonatal Early - Onset GBS Sepsis, January 2017, accessed from , 06/09/2017.Back to Table of ContentsDefinition of TermsThese definitions have been adapted from the International paediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in paediatrics ADDIN EN.CITE <EndNote><Cite><Author>Goldstein</Author><Year>2005</Year><RecNum>16</RecNum><DisplayText>(12)</DisplayText><record><rec-number>16</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1505185786">16</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goldstein, B.</author><author>Giroir, B.</author><author>Randolph, A.</author><author>International Consensus Conference on Pediatric, Sepsis</author></authors></contributors><auth-address>FCCM Oregon Health & Science University, Portland, OR, USA.</auth-address><titles><title>International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics</title><secondary-title>Pediatr Crit Care Med</secondary-title></titles><periodical><full-title>Pediatr Crit Care Med</full-title></periodical><pages>2-8</pages><volume>6</volume><number>1</number><keywords><keyword>Adolescent</keyword><keyword>Child</keyword><keyword>Clinical Trials as Topic</keyword><keyword>Humans</keyword><keyword>Infant, Newborn</keyword><keyword>International Cooperation</keyword><keyword>Multiple Organ Failure/classification/*diagnosis</keyword><keyword>Pediatrics/*standards</keyword><keyword>*Practice Guidelines as Topic</keyword><keyword>Sepsis/classification/*diagnosis</keyword></keywords><dates><year>2005</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1529-7535 (Print)
1529-7535 (Linking)</isbn><accession-num>15636651</accession-num><urls><related-urls><url>;(13)Systemic inflammatory response syndrome (SIRS): 2 of 4 (need either temperature instability or WCC to be one criteria): Abnormal WCC or IT ratioTemperature >38.5 of <36Tachycardia/bradycardiaTachypnoeaInfection: Positive culture from a sterile site or clinical symptoms of infectionSepsis: SIRS + proven or suspected infectionSevere sepsis: Sepsis plus evidence of organ dysfunctionSeptic shock: Sepsis with cardiovascular organ dysfunction leading to inadequate tissue perfusionBack to Table of ContentsSearch Terms Neonatology, Sepsis, Infection, Neonate, GBS, PROM, FeverBack to Table of ContentsAttachmentsAttachment 1:Algorithm 1: Flow chart for management of suspected early onset sepsis in term and late preterm (From 34 weeks gestation) newborns in PNW/NICU/SCNAttachment 2:Algorithm 2: Flow chart for management of preterm infants at risk of EOS in the NICUAttachment 3:Algorithm 3: Newborns attending ED or via the community midwives with suspected late onset sepsis (<28 days of age or ex-premature infants <28 days corrected gestational age) – adapted from the NSW Clinical Excellence Commission sepsis kills pathway ADDIN EN.CITE <EndNote><Cite><Author>kills</Author><RecNum>18</RecNum><DisplayText>(13)</DisplayText><record><rec-number>18</rec-number><foreign-keys><key app="EN" db-id="v92052xfo0wa9wetsrnvdzpn92apsda0s05v" timestamp="1505186370">18</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>CEC sepsis kills</author></authors></contributors><titles></titles><dates></dates><urls></urls></record></Cite></EndNote>(13)Disclaimer: This document has been developed by ACT Health, Canberra Hospital and Health Services specifically for its own use. Use of this document and any reliance on the information contained therein by any third party is at his or her own risk and Health Directorate assumes no responsibility whatsoever.Policy Team ONLY to complete the following:Date AmendedSection AmendedDivisional ApprovalFinal Approval 13 Dec 2017New DocumentED WY&CCHHS Policy Committee16 Oct 2018Removal of information pertaining to GBS monitoring and reference to the GBS Guideline addedHazel Carlisle Clinical Lead, WY&CHazel Carlisle Clinical Lead, WY&CThis document supersedes the following: Document NumberDocument NameAttachment 1: Algorithm 1: Flow chart for management of suspected early onset sepsis in term and late preterm (from 34 weeks gestation) newborns on PNW/in NICU/SCNFirst lineIV Benzylpencillin AND IV Gentamicin(If a mother is known to be colonised with or infected by a pathogen that is not sensitive to this regimen an alternative may need to be used/discussed with infectious diseases/microbiology)First line IF risk factors AND high suspicion of infectionIV Benzylpenicillin AND IV Amikacin Risk factors: Travel to a developing country/hospitalisation in a developing country in the past year. Known maternal colonisation with multi-resistant Gram negative organisms (if Amikacin sensitive)Severe sepsis/septic shockIV Meropenem and IV Vancomycin Attachment 2: Algorithm 2: Flow chart for newborns at risk of early onset sepsis <34 weeks in the NICUAttachment 3: Algorithm 3: Newborns attending ED or via the community midwives with suspected late onset sepsis (<28 days of age or ex-premature infants <28 days corrected gestational age) – adapted from the NSW Clinical Excellence Commission sepsis kills pathway ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- neonatal hypertrophic cardiomyopathy
- neonatal conjunctivitis peds in review
- aap guidelines neonatal conjunctivitis
- neonatal conjunctivitis treatment guideline
- neonatal conjunctivitis
- neonatal hypoxic ischemic encephalopathy
- neonatal hypoxic ischemic encephalopathy mri
- sjogren s syndrome neonatal lupus
- signs of neonatal respiratory distress
- neonatal respiratory distress radiology
- neonatal opioid withdrawal syndrome
- neonatal vancomycin dosing calculator